Imaging Biometrics Limited develops advanced imaging solutions for the medical field, focusing on the treatment and management of brain tumors. The company offers products such as IB Clinic, an automated imaging platform designed for high-volume cancer centers, and IB Zero G, which enhances MRI images using non-contrast inputs. Imaging Biometrics generates revenue through fee-per-exam processing services and commercial contracts with healthcare providers, including independent diagnostic imaging centers. The company operates primarily in the United States and is engaged in clinical trials and partnerships to expand its market presence.